GeneMedicine logo

GeneMedicine

Biopharmaceutical company focusing on R&D and commercializing its oncolytic adenovirus platform for cancer treatment.

11 employees · est. 2014 · Seoul, Korea South

VS
GenVivo, Inc. logo

GenVivo, Inc.

We are a clinical stage company with an off-the-shelf, vector-based platform, for immunotherapeutics in oncology

53 employees · San Marino, United States

GenVivo, Inc. is the larger of the two.

Side-by-Side Comparison

GeneMedicine GenVivo, Inc.
Founded
2014 Not tracked yet
Headquarters
Seoul, Korea South San Marino, United States
Employees
11 53 larger
Industry
Not tracked yet Biotechnology, Health Care
Funding Stage
Series A Not tracked yet
Total Funding
$15.00M Not tracked yet
Funding Rounds
1 Not tracked yet
Services
Gene Therapy Development, Research and Development, Contract Development and Manufacturing, Platform Technology Solutions, Biomedical Research Not tracked yet
Target Customers
Pharmaceutical Companies, Biotechnology Firms, Healthcare Providers, Research Institutions, Patients with Chronic Illnesses Not tracked yet
Taxonomy
Oncolytic Virotherapy, Adenovirus Platform, Viral Immunotherapy, Cancer Therapeutics, Gene And Cell Therapy, Intratumoral Administration, Systemic Delivery Platform, Tumor-Targeted Therapies, Immunogenic Cell Death, Immune Checkpoint Inhibitors, Advanced Cancer Treatment, Antitumor Immune Activation, Biomedical Engineering, Genetic Engineering, Synergistic Combination Therapy Oncology, Immunotherapeutics, Gene Delivery Technologies, Cancer Treatment, Clinical-stage Company, Patient Treatment Experience, Off-the-shelf Therapies, Novel Gene Therapies, Companion Diagnostics, Immunotherapies, Clinical-stage Cancer Companies, Cancer Vaccines, Tumor-killing Therapies, Patient Survival, Quality Of Life Improvement
Website
gene-medicine.com genvivoinc.com
GeneMedicine logo

About GeneMedicine

GeneMedicine is a biopharmaceutical company established in 2014 and headquartered in Korea South, positioned at the forefront of viral immunotherapy for cancer treatment. Specializing in R&D and commercialization of an advanced oncolytic adenovirus platform, the startup is creating groundbreaking th...

GenVivo, Inc. logo

About GenVivo, Inc.

GenVivo, Inc. is a clinical stage company with a vector-based platform for immunotherapeutics in oncology. The company's goal is to effectively treat cancer patients with the latest gene delivery technologies, as well as to enhance the overall patient treatment experience. GenVivo is dedicated to de...

We will tell you when either one moves

BounceWatch watches GeneMedicine and GenVivo, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at GeneMedicine and GenVivo, Inc. — by email.

Frequently Asked Questions

GeneMedicine — Biopharmaceutical company focusing on R&D and commercializing its oncolytic adenovirus platform for cancer treatment.. GenVivo, Inc. — We are a clinical stage company with an off-the-shelf, vector-based platform, for immunotherapeutics in oncology. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
GeneMedicine has raised $15.00M while GenVivo, Inc. has raised undisclosed funding.
GeneMedicine and GenVivo, Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare GeneMedicine with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at GeneMedicine on 2 Mar 2026, and GenVivo, Inc. on 13 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy